DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the JUPITER LIFE LINE HOSP L (JLHL) share price today?

JUPITER LIFE LINE HOSP L (JLHL) is trading at ₹1,553 on the NSE, down 0.06% on the day. Source: DocStoX.

What is the PE ratio of JUPITER LIFE LINE HOSP L?

JUPITER LIFE LINE HOSP L has a price-to-earnings (PE) ratio of 52.5 in the Healthcare sector.

What is the market capitalisation of JUPITER LIFE LINE HOSP L?

JUPITER LIFE LINE HOSP L has a market capitalisation of approximately ₹10,199 crore.

JUPITER LIFE LINE HOSP L

JLHL·NSE·Healthcare

₹1,553.00▼ -1.00 (-0.06%)

Healthcare · Hospitals

A steady, established business

Day₹1530.00

₹1561.20

52W₹1177

₹162584%

Open

₹1561.20

High

₹1561.20

Low

₹1530.00

Prev Close

₹1554.00

Volume

34.6K

VWAP

₹1551.18

Snapshot

Key fundamentals

Market Cap

₹10,199 Cr

P/E Ratio

52.48Expensive

P/B Ratio

6.16

EPS

₹29.59

Book Value

₹236.00

ROE

13.10%Average

ROCE

15.00%Decent

Dividend Yield

0.07%

Debt / Equity

0.38Moderate

Face Value

₹10.00

52W High

₹1625.00

52W Low

₹1177.10

Sector

Healthcare

Industry

Hospitals

Avoid

None moatHigh uncertainty

Fair value estimate

₹272

▼ 82.5%downside

Trading at ₹1,553 — 82% above our estimate

BearFair valueBull

₹231₹272₹396

/100

Business quality — Solid

Growth 88Profitability 51Efficiency 18Valuation 41

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 2/9)

Strengths

Low debt relative to equity
Revenue compounding 19% over 3 years
Profit growing 39% a year

Risks

Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

13% ROE fading to 13% over ~3 yrs, on ₹236 book

₹238

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹396

Analyst target

No analyst coverage

—

Blended fair value₹272

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 19% over 3 years
Profit growing 39% a year

Bear case

Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

52.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

13.1%Average

Above 15% is considered healthy for Indian equities

ROCE

15.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.38Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹10,199 Cr

P/B

6.16

EPS

₹29.59

Div Yield

0.07%

What changed

Recent changes

Domestic institutions-0.4% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 52.5×

Growth

Strong

+19% rev CAGR

Profitability

Healthy

13.1% ROE

Financial health

Comfortable

D/E 0.38

Momentum

N/A

No technicals

Today

Trading activity

Delivery %58.9%

Turnover₹536.21L Cr

Trades5,259

VWAP₹1551.18

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+18.9%

+25.3%

10Y

—

Profit

+38.5%

—

10Y

—

EPS

+31.9%

—

10Y

—

Profile

Pros

Company has delivered good profit growth of 143% CAGR over last 5 years

Watch-outs

Cons

Working capital days have increased from 24.3 days to 97.4 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Domestic institutions reduced 0.43 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

41%

Promoter

Promoters

40.9%0.00

Public

33.6%+0.43

FII / FPI

8.5%0.00

DII

17.0%-0.43

Total shareholders

32,985-635 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter40.91%

FII8.48%

DII17.01%

Public33.60%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]